4.2 Article

Optimal unplanned design modification in adaptive two-stage trials

Journal

PHARMACEUTICAL STATISTICS
Volume 21, Issue 6, Pages 1121-1137

Publisher

WILEY
DOI: 10.1002/pst.2228

Keywords

adaptive design; clinical trial; conditional error principle; optimal design; sample size calculation

Funding

  1. Deutsche Forschungsgemeinschaft (DFG) [KI 708/4-1, RA 2347/4-1]
  2. Universitatsklinikum Heidelberg

Ask authors/readers for more resources

Adaptive planning of clinical trials allows modifying the entire trial design at any time point mid-course. In this paper, we propose an approach to construct adaptive designs with defined features by solving an optimization problem for unplanned design reassessment. By using the conditional error principle, we present a method to optimally modify the trial design at an unplanned interim analysis while protecting the type I error rate.
Adaptive planning of clinical trials allows modifying the entire trial design at any time point mid-course. In this paper, we consider the case when a trial-external update of the planning assumptions during the ongoing trial makes an unforeseen design adaptation necessary. We take up the idea to construct adaptive designs with defined features by solving an optimization problem and apply it to the situation of unplanned design reassessment. By using the conditional error principle, we present an approach on how to optimally modify the trial design at an unplanned interim analysis while at the same time strictly protecting the type I error rate. This linking of optimal design planning and the conditional error principle allows sound reactions to unforeseen events that make a design reassessment necessary.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available